Armando Anido

Directeur/Membre du Conseil chez SCYNEXIS, INC. Fortune : 10 399 $ au 31/05/2026

Profil

Armando Anido currently works at SCYNEXIS, Inc., as Independent Director from 2019, Auris Medical AG, as Director from 2016, and Malvern Consulting Group, Inc., as President.
Mr. Anido also formerly worked at Auxilium Pharmaceuticals LLC, as President, Chief Executive Officer & Director in 2011, NuPathe, Inc., as Chief Executive Officer & Director from 2012 to 2014, Zynerba Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2014 to 2023, Adolor Corp., as Independent Director in 2011, Life Sciences Pennsylvania, as Director, Aviragen Therapeutics, Inc., as Independent Non-Executive Director from 2015 to 2018, Respira Therapeutics, Inc., as Independent Director from 2012 to 2014, Auris Medical Holding AG, as Independent Non-Executive Director, Altamira Therapeutics Ltd., as Non-Executive Director, MedImmune LLC, as Executive Vice President-Sales & Marketing from 1999 to 2006, Glaxo Wellcome, Inc., as Vice President-Central Nervous System Marketing from 1995 to 1999, and Lederle Laboratories, as Vice President-AntiInfectives from 1989 to 1995.
Mr. Anido received his undergraduate degree and Masters Business Admin degree from West Virginia University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
SCYNEXIS, INC. 0,02%	01/04/2026	14 750 ( 0,02% )	10 399 $	31/05/2026

Postes actifs de Armando Anido

Sociétés	Poste	Début
SCYNEXIS, INC.	Directeur/Membre du Conseil	21/01/2019
Auris Medical AG	Directeur/Membre du Conseil	01/04/2016
Malvern Consulting Group, Inc.	President	-

Anciens postes connus de Armando Anido

Sociétés	Poste	Fin
ZYNERBA PHARMACEUTICALS, INC.	Directeur Général	10/10/2023
Aviragen Therapeutics, Inc.	Directeur/Membre du Conseil	01/03/2018
Respira Therapeutics, Inc.	Directeur/Membre du Conseil	01/09/2014
NUPATHE INC	Directeur Général	01/03/2014
AUXILIUM PHARMACEUTICALS, INC.	Directeur Général	07/12/2011